Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Gemcitabine/Carboplatin in Advanced NSCLC
NCT01004731Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2001
- Primary completion
- Jan 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in non-small cell lung cancer (NSCLC), sponsored by University of Alabama at Birmingham. Started Jun 2001; status: completed.
02
Drugs
KL-140
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01004731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004731.